PRASCO 326 (Phenylephrine and guaifenesin SR 25 mg / 900 mg)

Pill imprint PRASCO 326 has been identified as Phenylephrine and guaifenesin SR 25 mg / 900 mg.

Guaifenesin/phenylephrine is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 25 mg / 900 mg is not a controlled substance under the Controlled Substance Act (CSA).

Phenylephrine and guaifenesin SR

Imprint:

PRASCO 326

Strength:

25 mg / 900 mg

Color:

White

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Upper respiratory combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Prasco Laboratories

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.